Friday - November 27, 2020
Perelman School of Medicine: Many Elderly Patients With Metastatic Renal Cell Carcinoma Benefit From Targeted Therapies
June 21, 2019
PHILADELPHIA, Pennsylvania, June 21 [TNSmedicalresearch] -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:

* * *

- Penn Study Investigated Real-World Treatment Outcomes Among Medicare Patients

* * *

Many elderly patients with metastatic renal cell carcinoma (RCC)--who are often underrepresented in clinical trials to treat the kidney cancer--are seeing overall survival benefits from treatment with . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products